Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Pain|December 19, 2006
Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammationYun-Sil Lee, Hyungsuk Kim, Jaime S Brahim, et al.Molecular Pain|September 17, 2010
Nitric oxide is negatively correlated to pain during acute inflammationMay Hamza, Xiao-Min Wang, Tongtong Wu, et al.Anesthesia and Analgesia|October 29, 2002
Attenuation of pain in a randomized trial by suppression of peripheral nociceptive activity in the immediate postoperative periodSharon M Gordon, Jaime S Brahim, Ronald Dubner, et al.The Journal of Pain|October 27, 2004
Comparison of experimental and acute clinical pain responses in humans as pain phenotypesHyungsuk Kim, John K Neubert, Janet S Rowan, et al.Molecular Pain|February 16, 2010
Kinin B1 receptors contributes to acute pain following minor surgery in humansMay Hamza, Xiao-Min Wang, Albert Adam, et al.Anesthesia and Analgesia|January 1, 2008
The differential effects of bupivacaine and lidocaine on prostaglandin E2 release, cyclooxygenase gene expression and pain in a clinical pain modelSharon M Gordon, Brian P Chuang, Xiao Min Wang, et al.Oncology|July 28, 2007
A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancerMatthew L Goldman, Neelima Denduluri, Arlene W Berman, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 10, 2008
PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutationTodd A Theman, Michael T Collins, David W Dempster, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 12, 2012
Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structureRachel I Gafni, Jaime S Brahim, Panagiota Andreopoulou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancerAntoinette R Tan, Xiaowei Yang, Arlene Berman, et al.Pageof 3